Opinion: NK3 receptor antagonists: the next generation of antipsychotics? (Q28286127)

Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis

21 January 2018

1 reference

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

The dopamine hypothesis of schizophrenia: a review

21 January 2018

1 reference

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

21 January 2018

1 reference

Serotonin receptors: their key role in drugs to treat schizophrenia

21 January 2018

1 reference

SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor

21 January 2018

1 reference

Tachykinins and tachykinin receptors: structure and activity relationships

21 January 2018

1 reference

Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing

21 January 2018

1 reference

Structure and gene organization of bovine neuromedin K precursor

21 January 2018

1 reference

Mammalian Tachykinin Receptors

21 January 2018

1 reference

The troubled story of tachykinins and neurokinins.

21 January 2018

1 reference

Tachykinin receptors: a radioligand binding perspective.

21 January 2018

1 reference

Identification of methionine134 and alanine146 in the second transmembrane segment of the human tachykinin NK3 receptor as reduces involved in species-selective binding to SR 48968.

21 January 2018

1 reference

In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system.

21 January 2018

1 reference

Detailed distribution of Neurokinin 3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study

21 January 2018

1 reference

Localization of striatal and nigral tachykinin receptors in the rat.

21 January 2018

1 reference

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

Increased spontaneous activity following substance P infusion into A10 dopaminergic area

21 January 2018

1 reference

Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra

21 January 2018

1 reference

Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism

21 January 2018

1 reference

The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro

21 January 2018

1 reference

Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study.

21 January 2018

1 reference

Evidence for modulation of dopamine-neuronal function by tachykinin NK3 receptor stimulation in gerbil mesencephalic cell cultures.

21 January 2018

1 reference

Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig.

21 January 2018

1 reference

Behavioural effects of selective tachykinin agonists in midbrain dopamine regions

21 January 2018

1 reference

The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats

21 January 2018

1 reference

Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus

21 January 2018

1 reference

The organization of recent and remote memories

21 January 2018

1 reference

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

21 January 2018

1 reference

Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801.

21 January 2018

1 reference

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

21 January 2018

1 reference

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

Variables associated with disparities in treatment of patients with schizophrenia and comorbid mood and anxiety disorders.

21 January 2018

1 reference

Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges

21 January 2018

1 reference

Substance P precursor and kininogen: their structures, gene organizations, and regulation

21 January 2018

1 reference

Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices

31 March 2020

1 reference

Highly selective agonists for substance P receptor subtypes

31 March 2020

1 reference

Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse

31 March 2020

1 reference